168 related articles for article (PubMed ID: 8592401)
1. A new model for pancreaticobiliary maljunction without bile duct dilatation: demonstration of cell proliferation in the gallbladder epithelium.
Kaneko K; Ando H; Umeda T; Murahashi O; Hiraiwa K; Niimi N; Hossain M; Ito T
J Surg Res; 1996 Jan; 60(1):115-21. PubMed ID: 8592401
[TBL] [Abstract][Full Text] [Related]
2. Proliferating cell nuclear antigen expression in the gallbladder with pancreaticobiliary maljunction.
Isozaki H; Okajima K; Hara H; Sako S; Mabuchi H
J Surg Oncol; 1997 May; 65(1):46-9. PubMed ID: 9179267
[TBL] [Abstract][Full Text] [Related]
3. Pathology and cellular kinetics of gallbladder with an anomalous junction of the pancreaticobiliary duct.
Hanada K; Itoh M; Fujii K; Tsuchida A; Hirata M; Ishimaru S; Iwao T; Eguchi N; Kajiyama G
Am J Gastroenterol; 1996 May; 91(5):1007-11. PubMed ID: 8633539
[TBL] [Abstract][Full Text] [Related]
4. Anomalous pancreaticobiliary ductal junction without bile duct dilatation in gallbladder cancer.
Elnemr A; Ohta T; Kayahara M; Kitagawa H; Yoshimoto K; Tani T; Shimizu K; Nishimura G; Terada T; Miwa K
Hepatogastroenterology; 2001; 48(38):382-6. PubMed ID: 11379314
[TBL] [Abstract][Full Text] [Related]
5. Surgical treatment for non-dilated biliary tract with pancreaticobiliary maljunction should include excision of the extrahepatic bile duct.
Hara H; Morita S; Ishibashi T; Sako S; Dohi T; Iwamoto M; Tanigawa N
Hepatogastroenterology; 2001; 48(40):984-7. PubMed ID: 11490854
[TBL] [Abstract][Full Text] [Related]
6. Risk factor for extrahepatic bile duct cancer in patients with anomalous pancreaticobiliary ductal union.
Jung YS; Lee KJ; Kim H; Kim WH; Kim IG; Yoo BM; Kim JH; Kim MW
Hepatogastroenterology; 2004; 51(58):946-9. PubMed ID: 15239220
[TBL] [Abstract][Full Text] [Related]
7. Studies on biliary tract carcinoma in the case with pancreaticobiliary maljunction.
Hara H; Morita S; Ishibashi T; Sako S; Dohi T; Otani M; Iwamoto M; Inoue H; Tanigawa N
Hepatogastroenterology; 2002; 49(43):104-8. PubMed ID: 11941930
[TBL] [Abstract][Full Text] [Related]
8. p53 gene mutation and p53 protein overexpression in a patient with simultaneous double cancer of the gallbladder and bile duct associated with pancreaticobiliary maljunction.
Kasuya K; Nagakawa Y; Matsudo T; Ozawa T; Tsuchida A; Aoki T; Itoi T; Itokawa F
J Hepatobiliary Pancreat Surg; 2009; 16(3):376-81. PubMed ID: 19183832
[TBL] [Abstract][Full Text] [Related]
9. Proliferative potential and K-ras mutation in epithelial hyperplasia of the gallbladder in patients with anomalous pancreaticobiliary ductal union.
Tanno S; Obara T; Fujii T; Mizukami Y; Shudo R; Nishino N; Ura H; Klein-Szanto AJ; Kohgo Y
Cancer; 1998 Jul; 83(2):267-75. PubMed ID: 9669809
[TBL] [Abstract][Full Text] [Related]
10. Clinical abnormalities in adults with pancreaticobiliary maljunction with and without bile-duct dilatation.
Tanaka K; Nishimura A; Ishibe R; Yoshimine M; Ogata S; Taira A
Can J Surg; 1995 Aug; 38(4):351-4. PubMed ID: 7634202
[TBL] [Abstract][Full Text] [Related]
11. Long-term results of treatment for pancreaticobiliary maljunction without bile duct dilatation.
Ohuchida J; Chijiiwa K; Hiyoshi M; Kobayashi K; Konomi H; Tanaka M
Arch Surg; 2006 Nov; 141(11):1066-70. PubMed ID: 17116798
[TBL] [Abstract][Full Text] [Related]
12. Analysis of c-Ki-ras oncogene and p53 immunocytochemistry in the gallbladder mucosa of an experimental dog model of anomalous arrangement of the pancreaticobiliary ducts.
Sasaki K; Kunitomo K; Yagi K; Masamune K; Komi N; Tashiro S
Tokushima J Exp Med; 1996 Dec; 43(3-4):101-6. PubMed ID: 9100457
[TBL] [Abstract][Full Text] [Related]
13. Pancreas divisum in pancreaticobiliary maljunction.
Kamisawa T; Tu Y; Egawa N; Tsuruta K; Okamoto A; Matsukawa M
Hepatogastroenterology; 2008; 55(81):249-53. PubMed ID: 18507118
[TBL] [Abstract][Full Text] [Related]
14. Cyclooxygenase-2 expression in the gallbladder of patients with anomalous arrangement of the pancreaticobiliary duct.
Fumino S; Tokiwa K; Ono S; Iwai N
J Pediatr Surg; 2003 Apr; 38(4):585-9. PubMed ID: 12677571
[TBL] [Abstract][Full Text] [Related]
15. Intestinal metaplasia in gallbladder correlates with high amylase levels in bile in patients with a morphologically normal pancreaticobiliary duct.
Sakamoto H; Mutoh H; Ido K; Satoh S; Kumagai M; Hayakawa H; Tamada K; Sugano K
Hum Pathol; 2009 Dec; 40(12):1762-7. PubMed ID: 19716161
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical detection of 8-hydroxy-2'-deoxyguanosine in gallbladder epithelium of patients with pancreaticobiliary maljunction.
Otani K; Shimizu S; Chijiiwa K; Yamaguchi K; Noshiro H; Tanaka M
Eur J Gastroenterol Hepatol; 2001 Nov; 13(11):1363-9. PubMed ID: 11692064
[TBL] [Abstract][Full Text] [Related]
17. Mucosal cell proliferation activity of the gallbladder in children with anomalous arrangement of the pancreaticobiliary duct.
Tokiwa K; Ono S; Iwai N
J Hepatobiliary Pancreat Surg; 1999; 6(3):213-7. PubMed ID: 10526054
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in pancreaticobiliary maljunction.
Matsumoto Y; Fujii H; Itakura J; Matsuda M; Nobukawa B; Suda K
J Hepatobiliary Pancreat Surg; 2002; 9(1):45-54. PubMed ID: 12021897
[TBL] [Abstract][Full Text] [Related]
19. Estrogen receptor expression in anomalous arrangement of the pancreaticobiliary duct.
Fumino S; Iwai N; Deguchi E; Kimura O; Ono S; Iwabuchi T
J Pediatr Surg; 2005 Nov; 40(11):1716-20. PubMed ID: 16291158
[TBL] [Abstract][Full Text] [Related]
20. Frequent expression of mucin core protein MUC1 in non-neoplastic gallbladder mucosa from patients with pancreaticobiliary maljunction.
Yamato T; Kurumaya H; Ohama K; Yamamichi N; Watanabe Y; Harada K; Sasaki M; Nakanuma Y
Liver; 1999 Aug; 19(4):281-7. PubMed ID: 10459625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
